Filters close
Released: 16-Apr-2012 11:55 AM EDT
Mount Sinai School of Medicine Students Recognized for Innovative Human Rights in Medicine Program
Mount Sinai Health System

Recognizing significant health disparities in the local community, these students joined together to develop a curriculum in which select students participate in community service and research projects with the help of a faculty mentor to acquire the skills they need to pursue social justice work in their careers.

13-Apr-2012 11:30 AM EDT
Scientists Identify FLT3 Gene as a Valid Therapeutic Target in Acute Myeloid Leukemia
Mount Sinai Health System

Through a groundbreaking new gene sequencing technology, researchers have demonstrated that the gene FLT3 is a valid therapeutic target in Acute Myeloid Leukemia, AML, one of the most common types of leukemia. The technique, developed by Pacific Biosciences, allows for the rapid and comprehensive detection of gene mutations in patients with AML. The findings, published online April 15 in Nature, are a result of collaboration among scientists at the University of California, San Francisco, Pacific Biosciences and Mount Sinai School of Medicine. The discovery may help lead to the development of new drugs to treat AML.

Released: 10-Apr-2012 11:15 AM EDT
David H. Koch Donates $10 Million to Mount Sinai’s Jaffe Food Allergy Institute
Mount Sinai Health System

David H. Koch, Executive Vice President of Koch Industries, has committed $10 million to the Jaffe Food Allergy Institute at The Mount Sinai Medical Center. The gift is one of the largest in the Institute's history and will create the David H. and Julia Koch Research Program in Food Allergy Therapeutics. The program will serve as a hub for drug discovery and vaccine development related to food allergy, and build upon the promising work already underway at the Institute. The donation will also be used to further the Institute's recruitment of leading researchers dedicated to the discovery of new food allergy therapeutics.

5-Apr-2012 11:15 AM EDT
New “Genetic Bar Code” Technique Establishes Ability to Derive DNA Information From RNA
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have developed a method to derive enough DNA information from non-DNA sources—such as RNA—to clearly identify individuals whose biological data are stored in massive research repositories. The approach may raise questions regarding the ability to protect individual identity when high-dimensional data are collected for research purposes. A paper introducing the technique appears in the April 8 online edition of Nature Genetics.

2-Apr-2012 1:40 PM EDT
Mutations in 3 Genes Linked to Autism Spectrum Disorders
Mount Sinai Health System

Mutations in three new genes have been linked to autism, according to new studies including one with investigators at Mount Sinai School of Medicine. The findings, in a trio of papers revealing new genetic targets in autism, are published in the April 4th online issue of the journal Nature. The studies provide new insights into important genetic changes and the many biological pathways that lead to autism spectrum disorders (ASD).

Released: 30-Mar-2012 2:55 PM EDT
Lung Cancers Detected by CT Screening Grow at Same Rate as Those Found Through Traditional Methods
Mount Sinai Health System

A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages. The data, published online March 27 in the journal Radiology, demonstrate that lung cancers found through annual CT screening are similar to those found in routine practice, both in terms of tumor growth rates and cell-type distribution. In fact, the report showed that 79 percent of the cases diagnosed through annual repeat CT scans were detected at clinical Stage I, the earliest and most treatable stage, compared to only 15 percent detected through traditional methods.

Released: 27-Mar-2012 3:00 PM EDT
Mount Sinai Presents Landmark Research At American College of Cardiology Meeting
Mount Sinai Health System

Mount Sinai School of Medicine researchers presented 86 abstracts and plenary sessions at the American College of Cardiology’s (ACC) 61st Annual Scientific Session, including ground-breaking research on aggressive statin therapy, the prevalence of unrecognized cardiovascular disease symptoms in women, and morbidity associated with non-adherence to medication after stent implantation.

20-Mar-2012 1:15 PM EDT
Marijuana-Like Chemicals Inhibit Human Immunodeficiency Virus (HIV) in Late-State AIDS
Mount Sinai Health System

Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV) found in late-stage AIDS.

14-Mar-2012 2:45 PM EDT
New Drug Now Available for Actinic Keratosis, a Common Pre-Cancerous Skin Condition
Mount Sinai Health System

A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are published in the March 15, 2012 issue of the The New England Journal of Medicine.

Released: 12-Mar-2012 10:00 AM EDT
Survey Reveals Pressures to Increase Volume of Colonoscopies Adversely Impacts How Gastroenterologists Perform the Screening and Could Potentially Affect Procedure Quality
Mount Sinai Health System

Researchers at Mount Sinai School of Medicine have found that 92 percent of more than 1,000 gastroenterologists responding to a survey believed that pressures to increase the volume of colonoscopies adversely impacted how they performed their procedures, which could potentially affect the quality of colon cancer screening. The findings, based on responses from members of the American Society for Gastrointestinal Endoscopy (ASGE), are published in the March 2012 issue of Gastrointestinal Endoscopy.

8-Mar-2012 10:30 AM EST
Researchers Identify Promising New Drug Target for Kidney Disease
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have identified a regulator protein that plays a crucial role in kidney fibrosis, a condition that leads to kidney failure. Finding this regulator provides a new therapeutic target for the millions of Americans affected by kidney failure.

6-Mar-2012 10:45 AM EST
Researchers Find 5 Risk Biomarkers for Crohn’s Disease In Jews of Eastern European Descent
Mount Sinai Health System

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn’s disease in Jews of Eastern European descent, also known as Ashkenazi Jews.

Released: 21-Feb-2012 1:00 PM EST
Mount Sinai First to Use Visually Guided Catheter Ablation System to Treat Atrial Fibrillation Patient in New U.S. Clinical Trial
Mount Sinai Health System

For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected by atrial fibrillation (AFib), one of the nation’s most common heart ailments. The device is the first catheter ablation system to incorporate a camera that allows doctors to see a direct, real-time image of the patient’s heart tissue during ablation.

9-Feb-2012 9:00 AM EST
Commonly-Used Postoperative Radiotherapy Does Not Improve Survival in Older People with Lung Cancer
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.

9-Feb-2012 4:00 PM EST
State Laws Allowing Young Adults To Join Their Parents’ Health Insurance Policy Until Age 26 Improved Access to Care
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine have found that laws permitting children to stay on their parents’ health insurance through age 26 result in improved access to health care compared to states without those laws. This analysis indicates the potential positive impact of a key provision of the Patient Protection and Affordable Care Act of 2010 (ACA). The study appears in the March issue of the journal Pediatrics, the official journal of the American Academy of Pediatrics.

Released: 6-Feb-2012 2:00 PM EST
Beating the Winter Blues
Mount Sinai Health System

Dr. Dan Iosifescu offers tips and tricks on beating the winter doldrums.

Released: 1-Feb-2012 7:00 AM EST
Decaffeinated Coffee May Help Improve Memory Function
Mount Sinai Health System

In an animal study, Mount Sinai researchers found that decaffeinated coffee may improve glucose utilization in the brain, reducing the risk for Type 2 diabetes and the brain dysfunction associated with some neurological disorders.

Released: 20-Jan-2012 9:00 AM EST
Chemical In Personal Care Products May Contribute To Child Obesity
Mount Sinai Health System

Researchers from the Children’s Environmental Health Center at The Mount Sinai Medical Center in New York have found an association between exposure to the chemical group known as phthalates and obesity in young children – including increased body mass index (BMI) and waist circumference.

29-Dec-2011 10:00 AM EST
Gestational Diabetes and Low Socioeconomic Status Raise Risk of ADHD
Mount Sinai Health System

In the first study of its kind, researchers at Queens College and Mount Sinai School of Medicine have found that low socioeconomic status (SES) and maternal gestational diabetes together may cause a 14-fold increased risk of attention deficit hyperactivity disorder (ADHD) in six year olds.

21-Nov-2011 9:00 AM EST
Researchers Discover Clues to Developing More Effective Antipsychotic Drugs
Mount Sinai Health System

Researchers from Mount Sinai School of Medicine, have identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia. The discovery should allow researchers to predict the effectiveness of novel compounds for the treatment of schizophrenia and other serious mental disorders and may accelerate the development of better antipsychotic drugs. The findings are published in the November 23 issue of Cell.



close
0.14469